Petrovax and Intellogic launch a project to use the Botkin.AI platform for studying the effect of Longidaze® among patients recovered from COVID-19
The joint project of Petrovax and Intellogic for testing the efficacy and safety of Longidaze® is the first in Russia and one of the first in the world. It applies artificial intelligence to determine the degree of lung damage on patients, including those recovered from COVID-19.
THE FIRST GROUP OF VOLUNTEERS ARE VACCINATED WITH AD5-NCOV CANDIDATE VACCINE IN RUSSIA
International clinical trial of Polyoxidonium® confirms its safety for COVID-19 treatment
